Evidence map›Paper›PMID 40707225›Full record

ArticleInternal medicine (Tokyo, Japan)2026

Disseminated Strongyloidiasis Following Chemoradiotherapy for Lung Cancer in a Patient Living in a Non-endemic Area in Japan.

Nobumasa Okumura, Atsushi Torii, Daisuke Suzuki, Kosuke Ito, Kahori Iwade, Kosuke Takahashi

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nobumasa OkumuraDepartment of Respiratory Medicine, Anjo Kosei Hospital, Japan.
Atsushi ToriiDepartment of Respiratory Medicine, Anjo Kosei Hospital, Japan.
Daisuke SuzukiDepartment of Infectious Diseases, Anjo Kosei Hospital, Japan.
Kosuke ItoDepartment of Respiratory Medicine, Anjo Kosei Hospital, Japan.
Kahori IwadeDepartment of Respiratory Medicine, Anjo Kosei Hospital, Japan.
Kosuke TakahashiDepartment of Respiratory Medicine, Anjo Kosei Hospital, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We herein report a case of disseminated strongyloidiasis in a 64-year-old man with human T-lymphotropic virus type 1 infection who developed the condition after undergoing chemoradiotherapy for lung cancer. Treatment included daily ivermectin, which eradicated Strongyloides stercoralis after 7 days but was interrupted after 14 days due to the development of skin rashes. After excluding ivermectin as the cause of the drug eruption, intermittent ivermectin was continued monthly for six months, with no recurrence of strongyloidiasis or bacteremia. This case highlights the importance of obtaining a comprehensive patient history and making an early diagnosis to improve the outcomes of disseminated strongyloidiasis.

Indexed as

ChemoradiotherapyLung NeoplasmsStrongyloidiasisAnimalsAntiparasitic AgentsHTLV-I InfectionsHumansIvermectinJapanMaleMiddle AgedStrongyloides stercoralisAntiparasitic AgentsIvermectindisseminated strongyloidiasishyperinfectionneglected tropical diseasesStrongyloides stercoralis

Identifiers

PMID40707225
PMCPMC12979673

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.